Renal Endocrine Flashcards

1
Q

is the principal circulating form of vitamin D.

A

25-hydroxycholecalciferol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The enzyme is responsible for the hydroxylation step necessary to produce 1,25-(OH)2-cholecalciferol from 25-hydroxycholecalciferol.

A

1-alpha-hydroxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Vitamin D3, which can be acquired from milk in the diet, is known as .

A

CHOLECALCIFEROL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When it comes to new bone, the role of vitamin D is to promote .

A

Mineralization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The major actions of 1,25-dihydroxycholecalciferol are on the , kidneys and bones.

A

INTESTINE
KIDNEY
BONES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

25-hydroxycholecalciferol is bound to a/an in plasma.

A

alpha-globulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

25-hydroxycholecalciferol is physiologically (active/inactive) .

A

INACTIVE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

On the intestine, 1,25-dihydroxycholecalciferol increases calcium and phosphate absorption, by inducing the synthesis of a vitamin D-dependent calcium-binding protein known as .

A

Calbindin D-28k

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The second major regulator of calcium and phosphate metabolism (after parathyroid hormone) is .

A

Vitamin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The enzyme 1-alpha-hydroxylase is (stimulated/inhibited) by low concentrations of calcium and phosphate.

A

STIMULATED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In the kidneys 25-hydroxycholecalciferol can be hydroxylated at the carbon-1 position to the active form known as .

A

1,25-(OH)2D3 (calcitriol).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

1,25-dihydroxycholecalciferol action on the kidney is to stimulate calcium (and/but not) phosphate absorption.

A

AND

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Vitamin D is a (polypeptide/steroid) hormone

A

Steroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cholecalciferol is produced in the skin from in the presence of ultraviolet light, and also acquired from the diet.

A

7-dehydrocholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The action of vitamin D is to (increase/decrease) both calcium and phosphate concentrations in plasma

A

INCREASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The hydroxylation of cholecalciferol is regulated by (positive/negative) feedback mechanisms.

A

Negative

17
Q

Cholecalciferol is hydroxylated in the liver to form

A

25-hydroxycholecalciferol.

18
Q

Calbindin D-28K is the calcium-binding protein induced by in the intestine.

A

Calcitriol

19
Q

Decreased plasma calcium and _____ concentration stimulate the enzyme 1-alpha-hydroxylase.

A

phosphate

20
Q

In bone, 1,25-dihydroxycholecalciferol acts together with to stimulate osteoclast activity and bone resorption.

A

PTH

21
Q

The enzyme 1-alpha-hydroxylase is stimulated by (hormone) .

A

PTH

22
Q

Cholecalciferol is physiologically (active/inactive)

A

INACTIVE

23
Q

Vitamin D increases the plasma concentration of calcium (and/but not of) phosphate.

A

AND

24
Q

Low concentrations of and phosphate stimulate the enzyme 1-alpha-hydroxylase.

A

Calcium

25
Q

Vitamin D2, which can be acquired from plant foods in the diet, is known as .

A

Ergocalciferol

26
Q

When hypoxia occurs there is increased production of , which is the first step in erythropoietin synthesis.

A

Hypoxia-Inducible factor 1 alpha

27
Q

Decreased function of renal tissue results in decreased erythropoietin synthesis, which can cause .

A

ANEMIA

28
Q

Hypoxia-inducible factor 1-alpha acts on fibroblasts in the renal cortex and medulla to cause synthesis of for erythropoietin.

A

mRNA

29
Q

When the oxygen content of arterial blood is (increased/decreased) , the kidney is signalled to produce more erythropoietin.

A

DECREASED

30
Q

is a treatment option for anemia of chronic renal failure.

A

Recombinant EPO

31
Q

The are the ideal site for erythropoietin synthesis because they can determine whether the decreased oxygen delivery is due to decreased blood flow or decreased oxygen content of arterial blood.

A

KIDNEYS

32
Q

Erythropoietin acts to induce differentiation of .

A

PROERTHYTOBLASTS